Superworth

Integra Lifesciences price to free cash flow IART

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Nov 2, 2026
12.3×
10-year median
34.9×
Against its 10-year history
0th
percentile: 0 is its lowest day, 100 its highest
10-year range
11.6× to 377×
Peer median
18.3×

Integra Lifesciences' price to free cash flow is 12.3× as of Nov 2, 2026.

That is below its ten-year median of 34.9×, lower than on 100% of days in the last ten years.

Over that time it ranged from 11.6× in Oct 2026 to 377× in Jul 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 18.3×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far12.3×11.6×377×
202552.1×42.9×71.8×
202445.3×22.4×50.3×
202331.0×15.8×31.8×
202224.3×16.8×24.4×
202119.3×18.0×38.2×
202034.2×19.7×45.4×
201945.0×35.7×47.8×
201836.7×36.7×72.5×
201764.2×16.2×67.7×
201616.7×14.8×65.0×
201543.9×32.2×60.8×
201457.4×50.1×292×
201327.2×27.2×29.5×
201226.0×12.1×27.0×
201115.2×14.3×24.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Integra Lifesciences' size, closest first, today.

CompanyPrice to free cash flow
IARTIntegra Lifesciences12.3×
IRMDIradimed38.9×
BVSBioventus11.7×
STAAStaar Surgicaln/m
CDRECadre17.3×
EYENational Vision27.6×
MOVMovado10.0×
LMATLemaitre Vascular25.2×
INSPInspire Medical Systems16.6×
TCMDTactile Systems Technology19.3×
UFPTUFP Technologiesn/m
Peer median18.3×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Integra Lifesciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.